Literature DB >> 25287257

2013-2014 updates in Peyronie's disease management.

Benjamin A Sherer1, Krishnan Warrior, Laurence A Levine.   

Abstract

The number of patients presenting with Peyronie's disease (PD) appears to be on the rise. This review provides an analysis of pertinent recent updates in the management of PD, focusing on data published within the past year. Objective benefit from injectable agents has been reported for years in mostly noncontrolled trials. The safety and efficacy of injectable collagenase clostridium histolyticum is now supported by data from a large-scale phase III randomized controlled trial. Other important advances have also been made in the surgical management of Peyronie's disease, including new modifications to proven surgical techniques and a variety of approaches that can help enhance and restore penile length.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25287257     DOI: 10.1007/s11934-014-0459-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  51 in total

1.  Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant erectile dysfunction: A single-center study.

Authors:  Laurence A Levine; Jonas Benson; Christopher Hoover
Journal:  J Sex Med       Date:  2010-08-16       Impact factor: 3.802

2.  Partial plaque excision and grafting (PEG) for Peyronie's disease.

Authors:  Laurence A Levine
Journal:  J Sex Med       Date:  2011-07       Impact factor: 3.802

3.  The combination of penile revascularization surgery with penile corrective techniques as an alternative to prosthesis implantation in patients with Peyronie's disease having ED: preliminary results.

Authors:  O Kayigil; E Okulu
Journal:  Int J Impot Res       Date:  2013-03-21       Impact factor: 2.896

4.  Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study.

Authors:  Salvatore Sansalone; Giulio Garaffa; Rados Djinovic; Stefano Pecoraro; Mauro Silvani; Guido Barbagli; Alessandro Zucchi; Giuseppe Vespasiani; Carla Loreto
Journal:  Asian J Androl       Date:  2011-07-11       Impact factor: 3.285

5.  Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.

Authors:  Fabio Castiglione; Petter Hedlund; Frank Van der Aa; Trinity J Bivalacqua; Patrizio Rigatti; Hein Van Poppel; Francesco Montorsi; Dirk De Ridder; Maarten Albersen
Journal:  Eur Urol       Date:  2012-09-24       Impact factor: 20.096

6.  Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction.

Authors:  U Ozturk; S Yesil; H N G Goktug; A Gucuk; C Tuygun; N C Sener; I Nalbant; M A Imamoglu
Journal:  Ir J Med Sci       Date:  2013-11-05       Impact factor: 1.568

Review 7.  Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.

Authors:  Martin Gelbard; Irwin Goldstein; Wayne J G Hellstrom; Chris G McMahon; Ted Smith; James Tursi; Nigel Jones; Gregory J Kaufman; Culley C Carson
Journal:  J Urol       Date:  2013-01-31       Impact factor: 7.450

8.  Comparison between AMS 700™ CX and Coloplast™ Titan inflatable penile prosthesis for Peyronie's disease treatment and remodeling: clinical outcomes and patient satisfaction.

Authors:  Eric Chung; Matthew Solomon; Ling DeYoung; Gerald B Brock
Journal:  J Sex Med       Date:  2012-12-04       Impact factor: 3.802

9.  Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation.

Authors:  Juan I Martínez-Salamanca; Alejandra Egui; Ignacio Moncada; Javier Minaya; Claudio Martínez Ballesteros; Luis Del Portillo; Ignacio Sola; Joaquín Carballido
Journal:  J Sex Med       Date:  2013-11-22       Impact factor: 3.802

10.  Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study.

Authors:  Laurence A Levine; Mark Newell; Frederick L Taylor
Journal:  J Sex Med       Date:  2008-03-26       Impact factor: 3.802

View more
  3 in total

1.  Is Peyronie's an IgG4-related disease?

Authors:  Mehmet Solakhan; Bünyamin Kısacık
Journal:  Eur J Rheumatol       Date:  2020-07-27

Review 2.  Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2015-08       Impact factor: 9.546

3.  Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis.

Authors:  Dehong Cao; Jinze Li; You Lu; Yin Huang; Bo Chen; Zeyu Chen; Yinzhi Shen; Liangren Liu; Qiang Wei
Journal:  Front Med (Lausanne)       Date:  2022-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.